Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.

Conclusion: These data indicate no clinically relevant pharmacokinetic interaction between pradigastat and rosuvastatin.
PMID: 25740267 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - March 5, 2015 Category: Cancer & Oncology Authors: Kulmatycki K, Hanna I, Meyers D, Salunke A, Movva A, Majumda T, Natrillo A, Vapurcuyan A, Rebello S, Sunkara G, Chen J Tags: Int J Clin Pharmacol Ther Source Type: research